Cutter Capital Management, LP Portfolio Holdings

Cutter Capital Management, LP

  • $339 Billion
  • Q3 2024

Cutter Capital Management, LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $339 Billion distributed in 27 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Gilead Sciences, Inc. with a value of $30.1B, Bristol Myers Squibb CO with a value of $29.7B, Royalty Pharma PLC with a value of $18.8B, Agilent Technologies, Inc. with a value of $17.9B, and Ultragenyx Pharmaceutical Inc. with a value of $15.9B.

Examining the 13F form we can see an increase of $7.5B in the current position value, from $331B to 339B.

Cutter Capital Management, LP is based out at New York, NY

Below you can find more details about Cutter Capital Management, LP portfolio as well as his latest detailed transactions.

Portfolio value $339 Billion
Healthcare: $328 Billion

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 27
  • Current Value $339 Billion
  • Prior Value $331 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 12 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 11 stocks
Track This Portfolio

Track Cutter Capital Management, LP Portfolio

Follow Cutter Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutter Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email